C148 Pill - pink capsule/oblong, 7mm
Pill with imprint C148 is Pink, Capsule/Oblong and has been identified as Lamotrigine 25 mg. It is supplied by Cipla Limited.
Lamotrigine is used in the treatment of Bipolar Disorder; Lennox-Gastaut Syndrome; Seizure Prevention; Epilepsy; Seizures and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for C148
Lamotrigine
- Imprint
- C148
- Strength
- 25 mg
- Color
- Pink
- Size
- 7.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Triazine anticonvulsants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Cipla Limited
- National Drug Code (NDC)
- 69097-0148 (Discontinued)
- Inactive Ingredients
-
lactose monohydrate,
sodium starch glycolate type A potato,
silicon dioxide,
povidone k30,
magnesium stearate,
ferric oxide red,
ferric oxide yellow,
ferrosoferric oxide
Note: Inactive ingredients may vary.
Related images for "C148"
More about lamotrigine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,845)
- Drug images
- Latest FDA alerts (6)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: triazine anticonvulsants
- Breastfeeding
- En español
Patient resources
- Lamotrigine drug information
- Lamotrigine Chewable Dispersible Tablets
- Lamotrigine Extended-Release Tablets
- Lamotrigine Orally Disintegrating Tablets
Other brands
Lamictal, Lamictal XR, Subvenite, Lamictal ODT, Lamictal CD
Professional resources
- Lamotrigine monograph
- Lamotrigine (FDA)
- Lamotrigine Chewable Tablet (FDA)
- Lamotrigine Extended Release Tablet (FDA)
- Lamotrigine ODT (FDA)
Other brands
Lamictal, Lamictal XR, Subvenite
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.